Theravance Biopharma (TBPH) Amortizatization of Intangibles (2015 - 2026)

Theravance Biopharma (TBPH) has 9 years of Amortizatization of Intangibles data on file, last reported at $1.1 million in Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $1.1 million, up 9.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.1 million (down 4.07% YoY), and the FY2025 annual result was $4.0 million, down 9.04% from the prior year.
• Amortizatization of Intangibles retreated to $1.1 million in Q1 2026 per TBPH's latest filing, from $1.1 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $1.7 million in Q4 2022 and troughed at $341000.0 in Q1 2022.
• A 5-year average of $1.0 million and a median of $1.0 million in 2023 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles sank 54.1% in 2022, then soared 202.35% in 2023.
• A 5-year view of Amortizatization of Intangibles shows it stood at $1.7 million in 2022, then slipped by 16.25% to $1.4 million in 2023, then declined by 26.26% to $1.1 million in 2024, then advanced by 5.13% to $1.1 million in 2025, then dropped by 4.61% to $1.1 million in 2026.
• Business Quant data shows TBPH's Amortizatization of Intangibles at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.0 million in Q3 2025.